Pharma mergers: FTC and DOJ to explore new ways of enforcing antitrust laws

Just when the pharma industry thought today’s $3 billion GSK buyout might kick off M&A season, the Department of Justice and the Federal Trade Commission said later in the afternoon they’re putting on a 2-day workshop in two weeks that will focus on “new approaches to enforcing the antitrust laws in the pharmaceutical industry.”

The virtual workshop will include a keynote from FTC Commissioner Rebecca Kelly Slaughter, who has previously sought to block key pharma mergers and recently pulled together international partners from Canada, the UK and the EU, to identify concrete and actionable steps to review and update their analyses of pharma mergers. This workshop is the culmination of the work of this group of regulators, known collectively as the Multilateral Pharmaceutical Merger Task Force, the FTC said.

It remains unclear the extent to which the FTC will do more than what it’s done…
Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.